Mutz Christopher
ANI Pharmaceuticals, Inc. · HEAD OF RARE DISEASE
Mutz Christopher is listed in filings as HEAD OF RARE DISEASE at ANI Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 13, 2026, including sale activity. Recent filings connect the profile to ANI Pharmaceuticals, Inc. (ANIP). The current snapshot covers public activity from Nov 18, 2024 to Mar 13, 2026. Reported amounts are shown as $226.5K to $245.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $267k3.6k shares | SellMar 9, 2026 | $74.18 | $81.76 | |
| $157k2.1k shares | SellMar 6, 2026 | $74.22 | $81.76 | |
| $31k417 shares | SellMar 2, 2026 | $74.00 | $81.76 | |
| $415k5.3k shares | SellFeb 20, 2026 | $78.02 | $81.76 | |
| $538k7k shares | SellFeb 12, 2026 | $76.55 | $81.76 | |
| $242k4k shares | SellMay 14, 2025 | $60.45 | $81.76 | |
| $375k6.5k shares | SellNov 15, 2024 | $57.70 | $81.76 |